Physician profile
Nathanial William Hansen
NPI 1124693288
$7,848.04
in general payments reported to CMS, 2019-2025
18 companies · $3,760 in 2025
The $3,760 reported for 2025 was more than what 87% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $185 · 2022: $462 · 2023: $1,456 · 2024: $1,986 · 2025: $3,760.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,001 · Travel and Lodging: $2,123 · Education: $77.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,001.07 |
| Travel and Lodging | $2,122.96 |
| Education | $77.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,264.62 | 2022-2025 | |
| Dermavant Sciences, INC. | $576.89 | 2023-2024 | Vtama |
| Ucb, INC. | $510.48 | 2024-2025 | Bimzelx |
| Janssen Biotech, INC. | $482.05 | 2023-2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $449.00 | 2021-2025 | Dupixent, Libtayo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $346.01 | 2024-2025 | Spevigo |
| E.R. Squibb & Sons, L.L.C. | $345.54 | 2023-2025 | Sotyktu |
| Janssen Scientific Affairs, LLC | $259.74 | 2022-2025 | Tremfya |
| Lilly USA, LLC | $224.16 | 2023-2025 | Olumiant, Taltz, Ebglyss |
| Sun Pharmaceutical Industries INC. | $221.24 | 2022-2025 | Winlevi, Absorica Ld, Ilumya |
| Biofrontera INC. | $198.34 | 2023-2025 | Ameluz, Xepi, Bf-Rhodoled |
| Novartis Pharmaceuticals Corporation | $194.50 | 2023-2025 | |
| Genzyme Corporation | $192.93 | 2022-2025 | |
| Leo Pharma INC. | $187.86 | 2025 | Anzupgo, Adbry, Spevigo |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $169.28 | 2021-2025 | Cabtreo, Siliq |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $121.60 | 2023 | |
| Galderma Laboratories, L.P. | $64.20 | 2022 | |
| Verrica Pharmaceuticals INC. | $39.60 | 2023-2024 | Ycanth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathanial Hansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.